Antidotes (A61P39/02)

A   Human necessities(312083)
A61P39        General protective or antinoxious agents(420)
A61P39/02                     Antidotes(57)
Bicillin-1 as means for prevention and early therapy of acute injuries caused by sulphur mustard // 2635476
FIELD: medicine.SUBSTANCE: application of the official medicinal product of penicillin - bicillin-1 as means for prevention and early therapy of acute lesions caused by the resorptive action of sulfur mustard is proposed.EFFECT: compared to the prototype, bicillin-1 has equal protective efficiency with respect to the resorptive action of sulfur mustard, but it is used in 20 times lesser dose and 5 times smaller volume with a more optimal way of administration, which indicates its advantage in case of mass use in preventive and early treatment.3 tbl, 3 ex
Complex compound of 5-hydroxy-1,3,6-trimethyluracyl with ambient acid, antidite activity and method of its production // 2634731
FIELD: chemistry.SUBSTANCE: compound is produced by mixing succinic acid and 5-hydroxy-1,3,6-trimethyluracil in an equimolar amount in an organic solvent by heating the reaction mixture. Preferably, the process is carried out at a temperature of up to 40°C followed by cooling and filtration of the precipitated crystals. The compound is produced in 90% yield.EFFECT: compound has antidote activity under conditions of exposure to toxic doses of poison - methaemoglobin-forming agent.4 cl, 5 tbl, 3 ex
Complex connection of 5-hydroxy-3,6-dimethyluracyl with succinic acid exhibiting membrane-stabilizing activity and method of its production // 2631238
FIELD: chemistry.SUBSTANCE: complex compound is produced by mixing equimolar amounts of 5-hydroxy-3,6-dimethyluracil with succinic acid in an organic solvent, followed by heating the reaction mixture for 1 hour at 70°C, cooling the reaction mixture and filtering the precipitated crystals. .EFFECT: having membrane-stabilizing and anti-radical activity, reduced toxicity in comparison with the known compounds of identical purpose.2 cl, 3 tbl, 4 ex
Bicillin-3 as means for prevention and early therapy of acute sulphur mustard injuries // 2629602
FIELD: pharmacology.SUBSTANCE: for prevention and early therapy of acute injuries with sulfur mustard, a known drug is proposed to be used, which is a penicillin preparation bicillin-3.EFFECT: protective effectiveness in terms of resorptive action of sulfur mustard, bicillin-3 is not inferior to the prototype, but it is used at a 20 times lesser dose and 5 times smaller volume with a more optimal route of administration, which indicates its advantage when necessary for mass use for prevention and early treatment.3 tbl, 3 ex
edical adsorbent and method for its obtaining // 2627464
FIELD: medicine.SUBSTANCE: medical adsorbent contains activated carbon in the form of spherical pellets, obtained by carbonizing and activation of regenerated cellulose in a spherical shape, and having average pore diameter of 1.5 to 2.2 nm, specific BET surface area of 700 to 3000 m2/g, average particle size of 115 to 1002 mcm, oxide content of 0.05 meq/g or more on the surface, and packing density of 0.4 to 0.8 g/ml. Method for adsorbent production comprises the steps of: spherical viscose conversion into regenerated spherical cellulose in an acid precipitation bath, and carbonizing of the resulting regenerated spherical cellulose at a temperature of 300°C to 700°C under a nitrogen atmosphere, and then steam activation at a temperature of 750°C to 1000°C, acid cleaning and heat treatment at a temperature of 500°C to 800°C. It can be used as a therapeutic or prophylactic agent for kidney disease or liver disease for oral administration.EFFECT: adsorbent has low dosage and excellent adsorption capacity and selective adsorption of toxins, it can shorten the activation time, it is economical and environmentally friendly.6 cl, 6 ex, 3 tbl
Therapeutic application of krill oil // 2625760
FIELD: medicine.SUBSTANCE: proposed: method for endotoxemia treatment by parenteral administration of a krill oil composition containing phospholipids derived from krill, in an oil-in-water emulsion for injection, wherein triglycerides comprise at least 60% of omega-3 fatty acids based on the total weight of fish oil triglyceride fatty acids; application of the said composition for the same purpose; method for high-lipophilic drugs excessive doses toxicity neutralisation or drugs harmful effects reduction, comprising parenteral administering of the said composition; use of krill oil containing phospholipids derived from krill as an emulsifier in an oil-in-water emulsion in the composition for injection, and its use for endotoxemia treatment during sepsis.EFFECT: stability and safety of claimed compositions for intravenous administration.5 cl, 9 tbl
Fodder additive for farm animals with enteric coating containing sodium metabisulphite for detoxification of vomitoxin // 2598722
FIELD: agriculture.SUBSTANCE: group of inventions relates to a fodder additive and a fodder product for farm animals, in which the particle-nucleus containing sodium metabisulphite and at least one binder has an enteric coating, herewith the thickness and the coating composition protect the sodium metabisulphite from decomposition to sulphur dioxide in an acidic aqueous medium of the stomach.EFFECT: group of inventions provides delivery of sodium metabisulphite into the lower segments of the gastrointestinal tract as an antidote in case of swallowed vomitoxin by animals.13 cl, 5 ex, 4 tbl

Antidote for carbon monoxide and hepatotoxic substances // 2584586
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to pharmacology, and describes antidote of carbon monoxide and hepatotoxic substances. Antidote is ammonia-zinc salt of soluble oxidised lignin with general formula (CxHyOz)n(NH3)k(Zn)m, where x = 14-16; y = 11-13; z = 5-7; n = 1.0-20; k = 1-30; m = 1-1.2.EFFECT: higher efficiency of treatment and prevention of poisoning with carbon monoxide (CO) and hepatotoxic agents and can be used for treating hypoxic states of various aetiology.1 cl, 7 ex, 11 tbl

Adsorbents for oral administration // 2583934
FIELD: medicine.SUBSTANCE: invention relates to use of activated carbon fibres as an adsorbent toxin level when administered orally. Invention relates to activated carbon fibre-containing adsorbent for oral administration for treating or preventing renal diseases or complications dialysis.EFFECT: treatment or prevention of renal diseases or complications of dialysis.7 cl, 4 dwg, 5 tbl, 18 ex

Antidote for carbon monoxide // 2581467
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to carbon monoxide antidote, which is 1-butyl-5-oxyiminopergidropyrimidin-2,4,6-trionata zinc acetate with structural formula: .EFFECT: invention can be used for treating and preventing of carbon monoxide (CO) poisoning, as well as for treatment of hypoxic states of various aetiology.1 cl, 9 tbl, 6 ex

ethod of protection of animals at dioxin poisoning // 2565406
FIELD: veterinary medicine.SUBSTANCE: method comprises applying within 30-60 days, depending on the animal species, on the tongue root of antiseptic stimulator - ASD-2 in an amount of 0.05-3 ml per head using a probe or dispenser. The bentonite is admixed with the feed at a dose of 2% of the daily diet of the animal.EFFECT: invention enables to improve the efficiency of treatment.3 tbl, 3 ex

Preparation with liposomes, containing succinic acid and propolis extract, possessing disintoxication and antioxidant activity // 2561591
FIELD: pharmacology.SUBSTANCE: capsules for per oral introduction contain liposomes, obtained at mixing of egg lecithin and cholesterol. Liposomes contain succinic acid and 10% alcohol extract of propolis as active substances, saccharose and water purified with the following component ratio, a g per 1 capsule: succinic acid - 0.1; alcohol propolis extract 10% - 0.2; 0.2% saccharose water solution - 0.02, suspension of phosphatidylcholine and cholesterol in ratio 1:0.2 - 0.3, as auxiliary substances.EFFECT: preparation has disintoxicating and antioxidant, as well as antiedematous, spasmolytic, anti-inflammatory, regenerating and antibacterial action, uniform release of active substances and expressed prolonged action, is convenient for independent application by patients.3 cl, 5 tbl, 6 ex

ethod for preventing acute exposure to organophosphates // 2555764
FIELD: medicine.SUBSTANCE: what is presented is a method for acute exposure to organophosphates with pronounced non-anticholinesterase mode of toxicity. A method consists in preventive administration of β-oestradiol 100 mg/kg 20-60 min prior to application of the toxic agent organophosphate.EFFECT: reducing the manifestations of first signs of the exposure, developing convulsions and complete elimination of animals' death experimentally, administering β-oestradiol 5 days or 1 day before the exposure has not been producing such an effect.3 tbl

ixed cobalt (ii) salts of ketocarboxylic and mercaptocarboxylic acids and hydrates thereof, or solvates thereof, methods for production and use thereof as cyanide antidotes // 2553275
FIELD: chemistry.SUBSTANCE: invention relates to mixed cobalt (II) salts of ketocarboxylic and mercaptocarboxylic acids of general formula (I): where R=Alk, R'=H, Alk, NH2, NHCOCH3, m=0-3, R"=H, Alk, COOH, n=0-3, where Alk=alkyl C1-C3, or to such compounds as a cobalt (II) salt of mercaptoacetic acid and pyruvic acid, a cobalt (II) salt of mercaptoacetic acid and α-ketoglutaric acid, a cobalt (II) salt of N-acetyl-L-cysteine and pyruvic acid, a cobalt (II) salt of α-ketoglutaric acid and L-cysteine, a cobalt (II) salt of pyruvic acid and 2-mercaptopropionic acid or hydrates or solvates thereof. A method of producing salts of general formula (I) is also disclosed.EFFECT: invention enables to obtain mixed cobalt (II) salts of ketocarboxylic and mercaptocarboxylic acids, having cyanide antidote activity.7 cl, 7 ex

Preparation possessing antitoxic activity and containing complex compound, methyluracil derivative with organic acid, and method for preparing it // 2533423
FIELD: medicine.SUBSTANCE: preparation shows an antitoxic activity, and can be used as an antidote for nitrite and nitrate poisoning. A complex compound of 5-hydroxy-6-methyluracil with ascorbic acid (5-hydroxy-6-methyluracil ascorbate) is described by formula: The preparation contains the complex compound in an amount of 0.3-0.4 wt %, and ascorbic acid - the rest. The method for producing the preparation consists in a reaction of 5-hydroxy-6-methyluracil and ascorbic acid taken in the relation of ascorbic acid: 5-hydroxy-6-methyluracil equal to 1:(0.0015-0.0022), in water as a solvent at a temperature of 20-40°C for 30-60 minutes. The complex compound is produced as shown by infra-red and NMR spectra. The antitoxic activity of 5-hydroxy-6-methyluracil on nitrite has been unknown before.EFFECT: water removal from the reaction mixture under low pressure.2 cl, 2 tbl, 1 ex
ethod of treatment of acute poisoning of animals with neonicotinoid insecticides // 2505298
FIELD: veterinary medicine.SUBSTANCE: invention is intended for treatment of acute poisoning of animals with neonicotinoid insecticides. The method comprises intravenous administration of diazepam, Ringer's solution and unitiol.EFFECT: method improves effectively the survival of animals, reduces the concentration of neonicotinoid insecticides in the body.3 tbl, 2 ex

Drug possessing antihypoxic, actoprotective, nootropic activities and having effect on physical efficiency, and based pharmaceutical composition // 2462245
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmacology and medicine and concerns the use of dihydrobromide 9-(2-diethylaminoethyl)-2-(3,4-dioxyphenyl)imidazo[1,2-a]benzimidazole of formula as a biologically active compound possessing high antihypoxic, actoprotective, nootropic activities and having a positive effect on physical efficiency, and a based pharmaceutical composition.EFFECT: preparing the compound possessing high antihypoxic, actoprotective, nootropic activities and having a positive effect on physical efficiency, and the based pharmaceutical composition.2 cl, 8 tbl, 3 ex

Vertebrata digestive tract detoxicant // 2452491
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to veterinary science. A detoxicant of polysilicic acid derivatives is specified in a group of reversed-phase sorbents.EFFECT: using the detoxicant enables practically eliminating toxic effects accompanying animal's poisoning.2 dwg

Polyfunctional enterosorbent // 2430731
FIELD: medicine, pharmaceutics.SUBSTANCE: invention concerns veterinary science. A polyfunctional enterosorbent contains schungite-containing minerals comprising silicon dioxide 15.0-70.0 wt %, with an average median particle size 15.0*10-6 m.EFFECT: invention provides higher efficacy on a wide spectrum of toxic substances, including mycotoxines, nitrates, nitrites, heavy metal salts, and also as an antibacterial and antioxidant agent.14 tbl, 14 ex

Antidote of carbon monoxide and method of its application // 2425676
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to zinc-containing antidote of lethal and severe poisonings with carbon monoxide. Claimed antidote represents intramolecular tricyclic complex of triethanolamine with zinc salts of inorganic or organic acids (2, 8, 9-trihydrozincatrane) with ratio of triethanolamine to zinc salts being 1:1. Invention also relates to method of protection against poisoning by carbon monoxide by peroral introduction into organism of zinc-containing antidote in 5 vol. % ethanol in dose range 20-60 mg/kg of body weight.EFFECT: prevention of lethal poisoning with carbon monoxide, higher efficiency and reducing acute toxicity of zinc-containing antidote.9 cl, 5 ex.
ethod of treating rats with acute verapamil intoxications // 2423986
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to toxicology, and can be used for treating rats with acute verapamil intoxications. That is ensured by administering sodium thiosulphate 15-20 mg per 100 g of rat's weights as a cardioprotector.EFFECT: method provides improved central venous pressure value.3 ex, 1 tbl

Zinc-containing ethanol poisoning antidote and method of treatment with its application // 2418580
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to zinc-containing antidote of lethal and severe poisonings with ethanol. Claimed antidote represents intramolecular tricyclic complex of triethanolamine with zinc salts of inorganic or organic acids (2, 8, 9-trihydrozincatran), the ratio of triethanolamine to zinc salts being 1:1. Invention also relates to method of treating ethanol poisoning by introduction into organism of zinc-containing antidote in 5 vol.% ethanol in dose range 30-60 mg/kg of body weight.EFFECT: prevention of lethal outcome in case of ethanol poisoning and reduction of acute toxicity of zinc-containing antidote.9 cl, 5 ex
Gamma-schizadrin synthesis method // 2401122
FIELD: chemistry.SUBSTANCE: Chinese magnolia is extracted with liquefied carbon dioxide. The obtained CO2 extract undergoes chromatographic separation on aluminium oxide and eluated with hexane. After eluation the obtained hexane fractions are frozen and recrystallised from the chloroform-hexane mixture in ratio of 1:10-3:10.EFFECT: high output of product.1 ex

ethod of cadmium nephropathy prevention in experimental animals suffering from chronic poisoning // 2366459
FIELD: medicine; veterinary science.SUBSTANCE: method consists in introduction to an experimental animal of Acyzol 30 mg/kg once a day combined with daily subcutaneous introduction of cadmium sulphate solution in a dose 0.1 mg/kg.EFFECT: prevention of cadmium toxic effect in chronic poisoning in experimental animals.2 cl, 1 tbl, 1 ex

edicinal agent // 2363463
FIELD: medicine.SUBSTANCE: invention relates to medicine and pharmaceutical industry, and more specifically to making tableted dosage form with prophylactic effect for arresting primed reaction to radiation and early transient incapacity. The agent contains ondansetron, methacin and caffeine in weight ratio ondansetron:methacin:caffeine 4:1:20-300.EFFECT: reduced adverse reaction, more specifically vomiting, diarrhea and reduction of physical activity.5 cl, 11 tbl
Osmotic diuretic possessing antitoxic activity in case of aliphatic alcohol poisoning // 2354390
FIELD: medicine.SUBSTANCE: claimed is remedy possessing antitoxic properties in case of aliphatic alcohol poisoning. As such polyosm - 30% solution of polyethylene oxide 400 is suggested. It is shown that polyosm protects animals against death (100% in control) in case of isopropyl alcohol poisoning.EFFECT: water content in lungs is analogous to index of intact animals at moderate reduction of respiration rate.6 tbl, 9 ex

1,3-di(3-piperidine-2-hydroxypropyl)-6-methyluracil for increase of capacity for survival and yeild of poultry // 2334745
FIELD: chemistry.SUBSTANCE: invention refers to veterinary science, in particular to products intended to increase capacity for survival and yield of poultry. For this purpose common composition 1,3-di(3-piperidine-2-hydroxypropyl)-6-methyluracil of formula: is used. Composition is characterised by natural resistance, antioxidant activity, activates nonspecific factors of immune system, as well as possesses medicinal properties to provide detoxification of nitrates and nitrites. Composition has the appearance of white powder, is highly soluble in water and can be added in specified doses to chickenfeed.EFFECT: production of composition providing increase of capacity for survival and yield of poultry.6 tbl, 5 ex

Remedy for poisoning and its complications treatment // 2331417
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to pharmaceutical industry and deals with acizol application as preventive and therapeutic means in neurotoxin poisoning cases. The present invention showed high efficacy of acizol in complex treatment for toxico-hypoxic encephalopathy and pneumonia (normalisation of homeostasis indices, lowering of mortality and disabling complications).EFFECT: lowering of the risk of complications in neurotoxin poisoning cases.15 tbl
ethod of dihydroquercetin production // 2330677
FIELD: medicine; pharmacology.SUBSTANCE: wood of Siberian or Daurian larch is debarked, cleaved and dried at 40-50°C to residual moisture 23-27%. Dried wood is chopped, and soluble substances are extracted with 75-85% ethyl alcohol aqueous solution at temperature 45-50°C in ratio raw material:extracting agent 1:(7-10). Further extracting agent is distilled off, and sawdust is supplied to press for additional alcohol return. Then extract aqueous part is cooled to 20-25°C within 20-30 minutes for isolation of resinous impurity accompanying dihydroquercetin (DHQ). Deresined extract aqueous part is added with methyltertbutyl ether (MTBE) in ratio 1: (0.3-0.45), and DHQ is reextracted within 2-3 hours. Extract ether part is isolated separate from aqueous part through sedimentation within 2-2.5 hours and supplied to MTBE evaporation, while target product is crystallised of hot water. Invention enables to produce DHQ with yield 2.2-2.5% of bone-dry wood mass with grade 90-96%.EFFECT: simplification of process and production of high-quality product.4 cl, 2 ex
eans for treatment and prevention of poisoning with heavy-metal compounds // 2325155
FIELD: medicine; veterinary.SUBSTANCE: method describes the use of 2,4-diphenyl-7,8-benzo-5,6-dihydroselenochromen as a means of treatment and prevention of poisoning with heavy metal compounds.EFFECT: higher resistance in animals and humans to poisoning with heavy-metal compounds.8 tbl, 1 ex
2,4,6-triphenyl-4h-selenipyrane as agent in treatment and prophylaxis of poisoning with arsenic compounds // 2314098
FIELD: organic chemistry, toxicology.SUBSTANCE: invention describes a method for using 2,4,6-triphenyl-4H-selenopyrane as an agent for treatment and prophylaxis of poisoning with arsenic compounds. Sodium arsenite was used as a toxicant. Using the claimed preparation reduces lethality of animals up to 40-60% (100% in control group). Also, significant improving blood indices and visceral organs of animals occurred, i. e. the severity degree of poisoning was decreased.EFFECT: enhanced effectiveness of agent.2 tbl
Pharmaceutical agent // 2309735
FIELD: medicine, pharmacy.SUBSTANCE: invention relates to biologically active substances displaying perspective using medicine, veterinary science, cosmetics and dairy industry. Agent comprises polyoxyarylene ester and hydroquinone in their ratio from 83:17 to 5:95, respectively. Agent comprises 2-(1-oxy-4-hydroxyphenylene)benzoquinone or 4-hydroxyphenylene-2,4-dioxybenzene as a polyoxyarylene ester. Method for preparing agent involves mixing polyoxyarylene ester with hydroquinone and wearing the prepared mixture up to formation of the uniform mass. Invention provides creature of a novel agent of the broad spectrum of effect, namely: antioxidant, antihypoxic, antitumor, radioprotective, immunostimulating and biocide effects.EFFECT: valuable properties of agent.7 cl, 20 tbl, 16 ex

Adsorbent for peroral administration // 2306941
FIELD: medicine.SUBSTANCE: claimed adsorbent contains spherical activated carbon having size diameter of 0.01-1 mm, specific surface determined in accordance to Langmuir equation of 1000 m2/g or more, ratio of diffraction intensities R of 1.4 or more (R is determined as R = (I15-I35)/(I24-I35) (1), wherein I15 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 15°C; I35 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 35°C; I24 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 24°C), and pore volume having diameter of 7.5-15000 nm is less than 0.25 mg/ml. In another embodiment claimed adsorbent contains abovementioned spherical activated carbon with modified surface. Also disclosed are pharmaceutical composition and method for prevention or treatment of kidney or liver diseases containing said adsorbent.EFFECT: new adsorbent for peroral administration.20 cl, 5 ex, 2 tbl, 12 dwg

2-methylthiopyrimido[4,5-b]indole protecting liver from poisoning with carbon tetrachloride // 2300534
FIELD: organic chemistry, medicine, hepatology.SUBSTANCE: invention relates to using 2-methylthiopyrimido[4,5-b]indole of the formula (1): showing melting point at 243°C (with decomposition) and value LD50 > 1000 mg/kg used in liver protection from poisoning with carbon tetrachloride. Proposed compound exceeds activity of the "Essentiale" as a comparison preparation.EFFECT: valuable medicinal property of compound, enhanced effectiveness.1 tbl

Adsorbent for peroral administration and agent for treatment or prevention of kidney or liver diseases // 2292211
FIELD: pharmaceutical industry.SUBSTANCE: claimed adsorbent contains spherical active carbon, obtained from thermosetting resin as carbon source, having particle size of 0.001-1 mm, specific surface determined by Langmuir adsorption equation of 1000 m2/g or more and pore volume of 7.5-15000 nm in diameter less than 0.25 ml/g. Also disclosed is adsorbent being similar to abovementioned one, wherein total content of acidic groups is 0.40-1.00 meq/g; total content of basic groups is 0.4-1.1 meq/g. Pharmaceutical compositions contain said adsorbents and pharmaceutically acceptable carriers and recipients. Agents of present invention are useful in treatment of kidney or liver diseases or disorders associated with uremic substance by administration of said adsorbents.EFFECT: products of increased selectivity.21 cl, 5 ex, 2 tbl, 11 dwg

Encapsulated form of acyzol // 2290928
FIELD: chemical and pharmacological industry.SUBSTANCE: invention relates to encapsulated form of Acyzol containing Acyzol and pharmaceutically acceptable fillers in specific component ratio.EFFECT: encapsulated mass with high technological characteristics, high biological availability and effectiveness of Acyzol component.5 tbl, 3 dwg
ethod for treating animals at dioxine intoxication // 2287331
FIELD: veterinary science.SUBSTANCE: in case of dioxine intoxication animals should be prescribed with dimephosphon at the dosage of about 50-150 mg/kg body weight daily for 10-30 d. The innovation provides decreased embryonic lethality in animals.EFFECT: higher efficiency of therapy.3 ex, 1 tbl

Agent for treatment of poisoning with organophosphorus poisonous substances // 2243770
FIELD: medicine, toxicology.SUBSTANCE: invention proposes applying 15% aqueous solution of 1-methyl-5-[2'-(benzyldimethylammonio)ethyl]carbamoyl pyridinium-2-aldoxime dichloride that exceeds the 15% solution of dipiroxime (TMB-4, trimedoxime bromide) used in native medicinal practice by the curative effectiveness. Invention can be used in urgent treatment of acute poisoning with organophosphorus poisonous substances eliciting neuroparalytic effect.EFFECT: enhanced effectiveness, valuable medicinal properties of agent.3 tbl

Derived imidazo-[1,2-a]-benzimidazole - tool, providing cerebroprotective effect in radiation damage // 2238938
The invention relates to the field of organic chemistry and medicine and relates to a derivative of imidazo-[1,2-a]-benzimidazole, specifically: 9-diethylaminoethyl-2-(3,4-dioksifenil)-imidazo-[1,2-a]-benzimidazole of dihydrobromide formula (I) providing cerebroprotective effect in radiation damage

2 ethylamino-4-piperidyl-6-[4'-methylcarbamyl-5'-methyl-1',2', 3'-triazole)-1-yl]-1,3,5 - triazine as an antidote // 2235096
The invention relates to organic chemistry, in particular to derive SIM-triazine-2-ethylamino-4-piperidyl-6-[(4’-methylcarbamyl-5’-methyl-1’,2’,3’,-triazole)-1-yl]-1,3,5-triazine structure:as an antidote from fetotoksicheskoe action of the herbicide 2,4 - dichlorophenoxyacetic acid on the sunflower sprouts
Drug // 2229882
The invention relates to a new combination drug, which can be used as a means of protecting the person from the early transient incapacitation and edema of the primary reaction to radiation

Stable crystalline salts of tetrahydrofolate acid (options), the method of production thereof and pharmaceutical composition // 2187508
The invention relates to new stable crystalline calcium or magnesium salts of (6R,S),(6S) - or (6R)-tetrahydrofolate acid, method for their production and pharmaceutical compositions based on them
 
2551028.
Up!